Doosan Group formed a task force to tap the global hydrogen market by reviewing the production, distribution, and utilization of hydrogen.
The market research task force will operate under its holding company Doosan Corp.
Doosan Group will also acquire and merge with other companies to grow its hydrogen business in the short term, it said.
Hydrogen is an environmentally friendly alternative to fossil fuels, as only water is created by vehicles and ships in the process of generating power. It has emerged as a future growth engine due to the South Korean government's efforts to foster environment-friendly industries.
Other major South Korean conglomerates, such as Hyundai Motor Group, Hyundai Heavy Industries Group, SK Group, and Hanwha Group, have been working to increase their presence in the hydrogen market.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



